Laurie Stelzer - 02 Jun 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Betsy Gelfand, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Jun 2023
Net transactions value
-$172,218
Form type
4
Filing time
02 Jun 2023, 19:15:36 UTC
Previous filing
24 Jan 2023
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $172,218 -4,647 -5.5% $37.06 80,015 02 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on June 01, 2022.